UPC Analytics
DEEN
Übersicht · Eingereicht: 2. Aug. 2024

UPC_CoA_464/2024

A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER

BerufungenHauptberufungCourt of AppealAppealCase Closed
Dieser Fall zitiert
In den Entscheidungen dieses Falls zitierte Quellen.

EPÜ-Artikel · 3

QuelleRechtsfrageBindungskraftAuszug
33(4)jurisdiction — same parties concept for consolidated proceedingsBindendThe concept of the "same parties" of Art. 33(4) UPCA must be understood as requiring the parties to be identical.
56inventive step — statutory standardBindendA European patent is only validly granted for an invention if ... it involves an inventive step ... if, having regard to the state of the art, it is not obvious to a person skilled in the art (Art. 56 EPC).
69(2)costs — equitable apportionment on partial successBindendThe Court of Appeal will therefore apportion the costs equitably pursuant to Art. 69(2) UPCA.

Verfahrensordnung · 2

QuelleRechtsfrageBindungskraftAuszug
49.2claim amendment — admissibility in defence to revocationBindendUnder R. 49.2 RoP, the Defence to revocation may include an application to amend the patent.
50.2claim amendment — subsequent request requires court permissionBindendPursuant to R. 50.2 in conjunction with R. 30.2 RoP, a subsequent request to amend the patent may only be admitted into the proceedings with the permission of the Court.

UPC-Berufungsgericht · 1

QuelleRechtsfrageBindungskraftAuszug
UPC_CoA_523/2024jurisdiction — territorial scope of injunction after Romania accessionAbgegrenztEdwards' reference to the Court of Appeal's order in the case of Syngenta v Sumi Agro (UPC_CoA_523/2024, order of 3 March 2025) cannot alter that assessment.
Zitiert in
Spätere UPC-Entscheidungen, die diesen Fall zitieren.
Zitiert inDatumRechtsfrageBindungskraftAuszug
UPC_CFI_337/2025

Munich CD

1. Dez. 2025inventive step and sufficiencyBindendin light of the Court of Appeal's recent decisions dated 25 November 2025, in cases UPC_CoA_464/2024 and related cases (Meril/Edwards), as well as cases UPC_CoA_528 and 529/2024 (Amgen/Sanofi and Regeneron).